NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Cancer Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Breast Cancer



New findings from J.R. Pasqualini and co-authors in the area of breast cancer published



October 21st, 2008

According to recent research from Paris, France, "Progesterone is metabolized in the normal breast mainly into 4-ene-pregnenes (e.g. 20 alpha-dihydroprogesterone, 20 alpha DHP) but, in contrast, in breast cancer tissue the 5 alpha-dihydropregnanes (e.g. 5 alpha-dihydroprogesterone, 5 alpha DHP) are prevalent. In the present study the effect of progesterone and its, main metabolites 20aDHP and 5aDHP on the aromatase activity in a stable aromatase-expressing estrogen receptor-positive human breast cancer cell line, MCF-7aro, was explored."

"The MCF-7aro cells were stripped of endogenous steroids and incubated with physiological concentrations of [H-3]-testosterone...


Source: Cancer Weekly (2008-10-21)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login